(Q53533566)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903089%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903089%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903089%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Hwan Jung Yun

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903089%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

10

Yung-Jue Bang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903089%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Bhumsuk Keam

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903089%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Sung-Bae Kim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903089%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Seong Hoon Shin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903089%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Keun-Wook Lee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903089%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Min Kyoung Kim

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903089%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Se-Hoon Lee

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903089%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Dok Hyun Yoon

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903089%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

English

0 references

publication date

22 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903089%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903089%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903089%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903089%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

2612-2617

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903089%20AND%20SRC:MED&resulttype=core&format=json

Clinicopathologic Predictors and Impact of Distant Metastasis From Adenoid Cystic Carcinoma of the Head and Neck

6 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29401

Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29401

Distant metastases of adenoid cystic carcinoma of the salivary glands and the value of diagnostic examinations during follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29401

Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29401

In vivo target modulation and biological activity of CHIR-258, a multitargeted growth factor receptor kinase inhibitor, in colon cancer models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29401

CHIR-258: a potent inhibitor of FLT3 kinase in experimental tumor xenograft models of human acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29401

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29401

Phase I study of dovitinib (TKI258), an oral FGFR, VEGFR, and PDGFR inhibitor, in advanced or metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29401

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29401

Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29401

A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29401

A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29401

A phase I pharmacokinetic and pharmacodynamic study of TKI258, an oral, multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29401

Phase II results of Dovitinib (TKI258) in patients with metastatic renal cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29401

Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29401

Population pharmacokinetic/pharmacodynamic modeling to assist dosing schedule selection for dovitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29401

Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29401

Salivary neoplasms: overview of a 35-year experience with 2,807 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29401

7 January 2021

DNA Copy Number Gains at Loci of Growth Factors and Their Receptors in Salivary Gland Adenoid Cystic Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29401

7 January 2021

Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck: a phase II study of the EORTC Head and Neck Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29401

7 January 2021

A phase II study of Imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29401

7 January 2021

Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29401

7 January 2021

Phase I/II and pharmacodynamic study of dovitinib (TKI258), an inhibitor of fibroblast growth factor receptors and VEGF receptors, in patients with advanced melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29401

7 January 2021

Identifiers

DOI

10.1002/CNCR.29401

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903089%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference